Cargando…

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis

Background: Hepatocellular carcinoma (HCC) is a typical inflammatory-related malignant tumor with complex immune tolerance microenvironment and poor prognosis. In this study, we aimed to construct a novel immune-related gene signature for the prognosis of HCC patients, exploring tumor microenvironme...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Changjing, Zhang, Chenyue, Sheng, Jie, Wang, Dan, Zhao, Yingke, Qian, Ling, Xie, Lin, Meng, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662347/
https://www.ncbi.nlm.nih.gov/pubmed/34899826
http://dx.doi.org/10.3389/fgene.2021.717319
_version_ 1784613415413612544
author Huang, Changjing
Zhang, Chenyue
Sheng, Jie
Wang, Dan
Zhao, Yingke
Qian, Ling
Xie, Lin
Meng, Zhiqiang
author_facet Huang, Changjing
Zhang, Chenyue
Sheng, Jie
Wang, Dan
Zhao, Yingke
Qian, Ling
Xie, Lin
Meng, Zhiqiang
author_sort Huang, Changjing
collection PubMed
description Background: Hepatocellular carcinoma (HCC) is a typical inflammatory-related malignant tumor with complex immune tolerance microenvironment and poor prognosis. In this study, we aimed to construct a novel immune-related gene signature for the prognosis of HCC patients, exploring tumor microenvironment (TME) cell infiltration characterization and potential mechanisms. Methods: A total of 364 HCC samples with follow-up information in the TCGA-LIHC dataset were analyzed for the training of the prognostic signature. The Least Absolute Shrinkage and Selector Operation (LASSO) regression based on the IRGs was conducted to identify the prognostic genes and establish an immune risk signature. The immune cell infiltration in TME was estimated via the CIBERSORT method. Gene Set Variation Analysis (GSVA) was conducted to compare the biological pathways involved in the low-risk and high-risk groups. Furthermore, paraffin sections of HCC tissue microarrays containing 77 patients from Fudan University Shanghai Cancer Center were used for IHC staining. The clinical characteristics of the 77 HCC patients were collected and summarized for survival analysis validation via the Kaplan–Meier (KM) method. Results: Three-gene signature with close immune correlation (Risk score = EPO * 0.02838 + BIRC5 * 0.02477 + SPP1 * 0.0002044) was constructed eventually and proven to be an effective prognostic factor for HCC patients. The patients were divided into a high-risk and a low-risk group according to the optimal cutoff, and the survival analysis revealed that HCC samples with high-risk immuno-score had significantly poorer outcomes than the low-risk group (p < 0.0001). The results of CIBERSORT suggested that the immune cell activation was relatively higher in the low-risk group with better prognosis. Besides, GSVA analysis showed multiple signaling differences between the high- and low-risk group, indicating that the three-gene prognostic model can affect the prognosis of patients by affecting immune-related mechanisms. Tissue microarray (TMA) results further confirmed that the expression of three genes in HCC tissues was closely related to the prognosis of patients, respectively. Conclusion: In this study, we constructed and validated a robust three-gene signature with close immune correlation in HCC, which presented a reliable performance in the prediction of HCC patients’ survival.
format Online
Article
Text
id pubmed-8662347
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86623472021-12-11 Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis Huang, Changjing Zhang, Chenyue Sheng, Jie Wang, Dan Zhao, Yingke Qian, Ling Xie, Lin Meng, Zhiqiang Front Genet Genetics Background: Hepatocellular carcinoma (HCC) is a typical inflammatory-related malignant tumor with complex immune tolerance microenvironment and poor prognosis. In this study, we aimed to construct a novel immune-related gene signature for the prognosis of HCC patients, exploring tumor microenvironment (TME) cell infiltration characterization and potential mechanisms. Methods: A total of 364 HCC samples with follow-up information in the TCGA-LIHC dataset were analyzed for the training of the prognostic signature. The Least Absolute Shrinkage and Selector Operation (LASSO) regression based on the IRGs was conducted to identify the prognostic genes and establish an immune risk signature. The immune cell infiltration in TME was estimated via the CIBERSORT method. Gene Set Variation Analysis (GSVA) was conducted to compare the biological pathways involved in the low-risk and high-risk groups. Furthermore, paraffin sections of HCC tissue microarrays containing 77 patients from Fudan University Shanghai Cancer Center were used for IHC staining. The clinical characteristics of the 77 HCC patients were collected and summarized for survival analysis validation via the Kaplan–Meier (KM) method. Results: Three-gene signature with close immune correlation (Risk score = EPO * 0.02838 + BIRC5 * 0.02477 + SPP1 * 0.0002044) was constructed eventually and proven to be an effective prognostic factor for HCC patients. The patients were divided into a high-risk and a low-risk group according to the optimal cutoff, and the survival analysis revealed that HCC samples with high-risk immuno-score had significantly poorer outcomes than the low-risk group (p < 0.0001). The results of CIBERSORT suggested that the immune cell activation was relatively higher in the low-risk group with better prognosis. Besides, GSVA analysis showed multiple signaling differences between the high- and low-risk group, indicating that the three-gene prognostic model can affect the prognosis of patients by affecting immune-related mechanisms. Tissue microarray (TMA) results further confirmed that the expression of three genes in HCC tissues was closely related to the prognosis of patients, respectively. Conclusion: In this study, we constructed and validated a robust three-gene signature with close immune correlation in HCC, which presented a reliable performance in the prediction of HCC patients’ survival. Frontiers Media S.A. 2021-11-26 /pmc/articles/PMC8662347/ /pubmed/34899826 http://dx.doi.org/10.3389/fgene.2021.717319 Text en Copyright © 2021 Huang, Zhang, Sheng, Wang, Zhao, Qian, Xie and Meng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Huang, Changjing
Zhang, Chenyue
Sheng, Jie
Wang, Dan
Zhao, Yingke
Qian, Ling
Xie, Lin
Meng, Zhiqiang
Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
title Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
title_full Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
title_fullStr Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
title_full_unstemmed Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
title_short Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
title_sort identification and validation of a tumor microenvironment-related gene signature in hepatocellular carcinoma prognosis
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662347/
https://www.ncbi.nlm.nih.gov/pubmed/34899826
http://dx.doi.org/10.3389/fgene.2021.717319
work_keys_str_mv AT huangchangjing identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis
AT zhangchenyue identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis
AT shengjie identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis
AT wangdan identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis
AT zhaoyingke identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis
AT qianling identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis
AT xielin identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis
AT mengzhiqiang identificationandvalidationofatumormicroenvironmentrelatedgenesignatureinhepatocellularcarcinomaprognosis